US Patent

US12280024 — Epinephrine formulations

Formulation · Assigned to Endo Operations Ltd · Expires 2035-03-13 · 9y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects pharmaceutical compositions of epinephrine and methods for making and administering them.

USPTO Abstract

Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.

Drugs covered by this patent

Patent Metadata

Patent number
US12280024
Jurisdiction
US
Classification
Formulation
Expires
2035-03-13
Drug substance claim
No
Drug product claim
Yes
Assignee
Endo Operations Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.